Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.
暂无分享,去创建一个
[1] C. Ker,et al. Assessment of serum and bile levels of CA19‐9 and CA125 in cholangitis and bile duct carcinoma , 1991, Journal of gastroenterology and hepatology.
[2] Y. Nakanuma,et al. Over‐expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis , 2008, The Journal of pathology.
[3] Y. Nakanuma,et al. Carcinoembryonic antigen and blood group‐related carbohydrate antigens in glycoproteins in human bile in hepatolithiasi , 1996, Hepatology.
[4] Masakazu Yamamoto,et al. Wisteria floribunda agglutinin‐positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma , 2010, Hepatology.
[5] Y. Nakanuma,et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.
[6] M. Manns,et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis , 2011, Hepatology.
[7] S. Shiesh,et al. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. , 2002, Hepato-gastroenterology.
[8] C. Georgopoulos,et al. Role of the major heat shock proteins as molecular chaperones. , 1993, Annual review of cell biology.
[9] K. Endo,et al. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. , 1990, The American journal of gastroenterology.
[10] S. Charette,et al. The Interaction of HSP27 with Daxx Identifies a Potential Regulatory Role of HSP27 in Fas‐Induced Apoptosis , 2000, Annals of the New York Academy of Sciences.
[11] M. Gleave,et al. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells , 2007, Molecular Cancer Therapeutics.
[12] A. Bergquist,et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.
[13] D. Iliopoulos,et al. Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. , 1989, Journal of the National Cancer Institute.
[14] Y. Nimura,et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[15] Y. Atomi,et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria , 2007, Modern Pathology.
[16] A. Saluja,et al. Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. , 2009, Gastroenterology.
[17] Y. Atomi,et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: Preliminary report based on interobserver agreement , 2005, Pathology international.
[18] M. Lerch,et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. , 2007, Cancer research.
[19] K. Lillemoe,et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. , 1996, American journal of surgery.
[20] Y. Nimura,et al. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. , 2004, Human pathology.
[21] Michael Gregor,et al. Serum and bile markers for cholangiocarcinoma. , 2004, Seminars in liver disease.
[22] F. Prat,et al. Bile levels of carcino‐embryonic antigen in patients with hepatopancreatobiliary disease , 1996, European journal of gastroenterology & hepatology.
[23] C. Lagrasta,et al. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma , 2007, BMC Cancer.
[24] Yabing Chen,et al. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma. , 2007, International journal of oncology.
[25] G. Kroemer,et al. Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties , 2006, Cell cycle.
[26] Y. Nakanuma,et al. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. , 2008, Human pathology.
[27] H. Friess,et al. Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. , 2007, Clinical chemistry.
[28] Yasunori Sato,et al. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. , 2009, World journal of hepatology.